Transmission-blocking vaccines: uses and current status of development (Q39122635)

9 September 2017

1 reference

title

Transmission-blocking vaccines: uses and current status of development (English)

1 reference

9 September 2017

Kaslow DC

1

1 reference

9 September 2017

1 February 1997

1 reference

International Journal for Parasitology

9 September 2017

1 reference

9 September 2017

27

1 reference

9 September 2017

2

1 reference

9 September 2017

183-189

1 reference

Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Malaria transmission blocked by immunisation with gametes of the malaria parasite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Successful immunization against the sexual stages of Plasmodium gallinaceum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Changes in infectiousness of malarial gametocytes. II. Analysis of the possible causative factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Transmission-blocking immunity against malaria and other vector-borne diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Induction of plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Further characterization of interactions between gamete surface antigens of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Transmission blocking antibody of the Plasmodium falciparum zygote/ookinete surface protein Pfs25 also influences sporozoite development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Plasmodium gallinaceum: erythrocyte factor essential for zygote infection of Aedes aegypti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Crystallization, sequence and preliminary crystallographic data for transmission-blocking anti-malaria Fab 4B7 with cyclic peptides from the Pfs25 protein of P. falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Plasmodium falciparum sexual stage antigens: Immunogenicity and cell-mediated responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Identification of a peptide sequence of the 25 kD surface protein of Plasmodium falciparum recognized by transmission-blocking monoclonal antibodies: implications for synthetic vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2896%2900148-8

10.1016/S0020-7519(96)00148-8

7 January 2021

Identifiers

DOI

1 reference

release_h7sk7b754bhmxdi6b7ulffducq

9 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h7sk7b754bhmxdi6b7ulffducq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9088989

1 reference

PubMed ID

9088989